24 Apr 2020 --- Many businesses active in the gut health space, including Probi and Lehvoss Nutrition, have seen a recent boost to their immunity-related products as consumers leave no stone unturned in safeguarding their health amid the COVID-19 pandemic. With lockdown measures unlikely to lift entirely until a pharmaceutical treatment is found – which could be over a year away – probiotics and postbiotics could provide an avenue of maintaining health in the meantime, with Biosearch Life launching a clinical trial examining the effect of its Hereditum Immunactiv K8 product on COVID-19. NutritionInsight speaks to industry players and weighs up how far the digestive health industry can go in the fight against COVID-19.
